Last edition
News about "diabetic macular edema therapy India"
Bayer Updates Access Model for Eylea 2mg in India
Bayer revises its access model for Eylea 2mg in India to expand patient eligibility and reduce upfront costs, enabling earlier treatment for retinal diseases.
Diabetic Macular Edema Therapy India | 08/04/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members